$5.36
0.75%
Nasdaq, Nov 16, 11:28 am EST. Market open.
ISIN
US78349D1072
Symbol
RXST

RxSight Inc Stock price

$5.32
+0.79 17.44% 1M
-0.23 4.14% 6M
-5.10 48.94% YTD
-4.26 44.47% 1Y
-20.56 79.44% 3Y
-6.76 55.96% 5Y
-10.68 66.75% 10Y
-10.68 66.75% 20Y
Nasdaq, Closing price Fri, Nov 13 2026
-0.06 1.12%

Is RxSight Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,087 stocks worldwide.

Key metrics

Basic
Market capitalization
$223.1m
Enterprise Value
$-31.6m
Net debt
positive
Cash
$254.7m
Shares outstanding
41.9m
Valuation
P/E
negative
P/S | estimate
1.8 | 1.5
EV/Sales | estimate
negative | negative
EV/FCF | ex SBC
negative | 2.6
P/B
0.9
Financial Health
Equity Ratio
88.4%
Return on Equity
-14.1%
ROCE
-23.2%
ROIC
-221.4%
Debt/Equity
0.0
Share-Based Compensation & Dilution
SBC | % of Revenue
$30.9m | 25.3%
SBC as % of FCF
165.6%
SBC Growth 1Y
-0.7%
Share Count Growth 1Y
2.1%
Shareholder Yield
-2.1%
Financials
Revenue | estimate
$121.8m | $149.7m
EBITDA
$-57.8m
EBIT
$-61.5m
Net Income
$-53.4m
Free Cash Flow | ex SBC
$18.6m | $-12.2m
Growth
Revenue | estimate
-14.3% | 11.3%
EBITDA
-36.0%
EBIT
-35.1%
Net Income
-49.3%
Free Cash Flow
184.0%
Margin
Gross
76.1%
EBITDA
-47.5%
EBIT
-50.4%
Net
-43.8%
Free Cash Flow | ex SBC
15.3% | -10.0%
More
EPS
$-1.3
FCF per Share
$0.4
Short interest
9.1%
Employees
461
Rev per Employee
$290.0k

RxSight Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a RxSight Inc forecast:

1x Buy
7%
9x Hold
60%
5x Sell
33%

Analyst Opinions

15 Analysts have issued a RxSight Inc forecast:

Buy
7%
Hold
60%
Sell
33%

RxSight Inc Events

Past Events
NOV
3
Q3 2026 Earnings Call
13 days ago
AUG
5
Q2 2026 Earnings Call
3 months ago
JUL
7
Q2 2026 Earnings Call
4 months ago
MAY
13
Bank of America Global Healthcare Conference 2026
6 months ago
MAY
6
Q1 2026 Earnings Call
6 months ago
FEB
25
Q4 2025 Earnings Call
9 months ago
JAN
13
44th Annual J.P. Morgan Healthcare Conference
10 months ago
NOV
5
Q3 2025 Earnings Call
about one year ago

Financial data from RxSight Inc

Sep '26
+/-
%
122 122
14% 14%
100%
- Direct Costs 29 29
18% 18%
24%
93 93
13% 13%
76%
- Selling and Administrative Expenses 117 117
4% 4%
96%
- Research and Development Expense 37 37
5% 5%
30%
-58 -58
36% 36%
-47%
- Depreciation and Amortization 3.61 3.61
23% 23%
3%
EBIT (Operating Income) EBIT -61 -61
35% 35%
-50%
Net Profit -53 -53
49% 49%
-44%

In millions USD.

Don't miss a Thing! We will send you all news about RxSight Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

RxSight Inc Stock News

Neutral
GlobeNewsWire
●
13 days ago
ALISO VIEJO, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today reported financial results for the quarter ended September 30, 2026.
Neutral
GlobeNewsWire
●
24 days ago
ALISO VIEJO, Calif., Oct. 23, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced that on October 23, 2026, RxSight granted inducement stock options to purchase a total of 236,456 shares of RxSight's common stock to two new non-executive officer employees in connection with the commencement of their employment with RxSight. RxSight also agreed to grant inducement restricted st...
More RxSight Inc News

Company Profile

RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. It also commercializes adjustable intraocular lens (IOL) that is customized after cataract surgery The company was founded by Robert Grubbs and Daniel Schwartz on March 5, 1997 and is headquartered in Aliso Viejo, CA.

Head office United States
CEO Dr. Kurtz
Employees 461
Founded 1997
Website www.rxsight.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today